Ulcerative pyoderma gangrenosum in inflammatory bowel disease

Lancet Gastroenterol Hepatol. 2019 Jun;4(6):488. doi: 10.1016/S2468-1253(19)30038-X.

Authors

Ilaria Motta¹, Giovanni Perricone²

Affiliations

¹ Infectious Diseases Unit, Department of Medical Sciences, University of Turin, Italy.
² Hepatology and Gastroenterology Unit, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy; Liver Failure Group, UCL Institute for Liver and Digestive Health, UCL Medical School, Royal Free Hospital, London, UK. Electronic address: giovanniperricone@gmail.com.

PMID: 31070128
DOI: 10.1016/S2468-1253(19)30038-X

No abstract available

Publication types

Case Reports

MeSH terms

Adult
Colitis, Ulcerative / complications*
Colitis, Ulcerative / drug therapy
Dermatologic Agents / therapeutic use
Foot Ulcer / pathology*
Humans
Infliximab / therapeutic use
Male
Negative-Pressure Wound Therapy
Pyoderma Gangrenosum / etiology*
Pyoderma Gangrenosum / therapy

Substances

Dermatologic Agents
Infliximab